# clm_66A870C2CD56

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: produces  
value: Atripla  
valid_from: undated  
valid_to: null  
published: 2018-02-27  
recorded: 2026-11-08  
confidence: 0.80  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-10  
cite: AsOf. "Gilead Sciences produces: Atripla", undated. Claim clm_66A870C2CD56, https://asof.is/claim/clm_66A870C2CD56, accessed 2026-11-11. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm.  
checked: 2026-11-10 · its source page states the value and the date  

> We may continue to purchase efavirenz from BMS as needed to continue manufacturing Atripla for the United States and Canada markets.

What https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm (primary, published 2018-02-27)
- https://www.wikidata.org/wiki/Q663596 (secondary, Wikidata)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.